Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

Non-Clinical Contribution to Clinical Trials during Lead Optimization Phase.

Martínez Muñoz L.

Behav Sci (Basel). 2018 Jan 24;8(1). pii: E17. doi: 10.3390/bs8010017.

2.

The regulatory framework for similar biotherapeutic products in Cuba.

Hechavarría Núñez Y, Pérez Massipe RO, Orta Hernández SD, Muñoz LM, Jacobo Casanueva OL, Pérez Rodríguez V, Domínguez Morales RB, Pérez Cristiá RB.

Biologicals. 2011 Sep;39(5):317-20. doi: 10.1016/j.biologicals.2011.08.005. Epub 2011 Sep 17. Review.

3.

Adjuvants: present regulatory challenges.

Pascual DM, Morales RD, Gil ED, Muñoz LM, López JE, Casanueva OL.

Vaccine. 2006 Apr 12;24 Suppl 2:S2-88-9. Review.

PMID:
16823941

Supplemental Content

Loading ...
Support Center